About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Sponsored by

Translational Lung Cancer Research is sponsored by General Hospital of Eastern Theater Command, Nanjing, China

Sponsored by

Consensus

Uniportal video-assisted thoracic surgery for the treatment of lung cancer: a consensus report from Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS)
Dingpei Han, Yuqin Cao, Han Wu, Haifeng Wang, Lei Jiang, Deping Zhao, Feng Yao, Shuben Li, Chong Zhang, Bin Zheng, Junqiang Fan, Yongde Liao, Bin Qiu, Fengwei Tan, Chun Chen, Yuming Zhu, Shugeng Gao, Hecheng Li

Original Article

Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non- small cell lung cancer (NSCLC) patients
Olga V. Pankova, Evgeny O. Rodionov, Sergey V. Miller, Sergey A. Tuzikov, Liubov A. Tashireva, Tatiana S. Gerashchenko, Evgeny V. Denisov, Vladimir M. Perelmuter
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives
Sabine Wessels, Thomas Muley, Petros Christopoulos, Michael Meister, Ingrid Heinzmann-Groth, Arne Warth, Esther Herpel, Simone Hummler, Ursula Klingmüller, Jonas Kuon, Claus-Peter Heussel, Ralf Eberhardt, Felix J. F. Herth, Hauke Winter, Helge Bischoff, Albrecht Stenzinger, Martin Reck, Rudolf Maria Huber, Michael Thomas, Marc A. Schneider
Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy
Young Kwang Chae, Won Bin Kim, Andrew A. Davis, Lee Chun Park, Jonathan F. Anker, Nicholas I. Simon, Kyunghoon Rhee, Junho Song, Anderson Cho, Sangmin Chang, Taeyeong Ko, Michael Oh, Manali Bhave, Pedro Viveiros
Molecular differences across invasive lung adenocarcinoma morphological subgroups
Bo Ci, Donghan M. Yang, Ling Cai, Lin Yang, Luc Girard, Junya Fujimoto, Ignacio I. Wistuba, Yang Xie, John D. Minna, William Travis, Guanghua Xiao
Does size matter? —a population-based analysis of malignant pleural mesothelioma
Jiaxi He, Songhui Xu, Hui Pan, Shuben Li, Jianxing He
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors
Sangtian Liu, Fei Zhou, Zhiyu Liu, Anwen Xiong, Yijun Jia, Sha Zhao, Chao Zhao, Xuefei Li, Tao Jiang, Ruoshuang Han, Meng Qiao, Yiwei Liu, Yayi He, Jiayu Li, Wei Li, Guanghui Gao, Shengxiang Ren, Chunxia Su, Caicun Zhou
An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer
Dirk Rades, Rapha Haus, Stefan Janssen, Steven E. Schild
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
Andrea Moreno-Manuel, Eloisa Jantus-Lewintre, Ines Simões, Fernando Aranda, Silvia Calabuig-Fariñas, Esther Carreras, Sheila Zúñiga, Yvonne Saenger, Rafael Rosell, Carlos Camps, Francisco Lozano, Rafael Sirera
EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes
Alexandra Pender, Curtis Hughesman, Elaine Law, Amadea Kristanti, Kelly McNeil, Selina Wong, Tracy Tucker, Ian Bosdet, Sean Young, Janessa Laskin, Aly Karsan, Stephen Yip, Cheryl Ho
Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients
Menno Tamminga, Lisa Oomens, T. Jeroen N. Hiltermann, Kiki C. Andree, Arjan Tibbe, Joska Broekmaat, Ed Schuuring, Leon W. M. M. Terstappen, Harry J. M. Groen
Cancer-associated changes of emotional brain network in non-nervous system metastatic non-small cell lung cancer patients: a structural connectomic diffusion tensor imaging study
Siwen Liu, Xiaoyou Li, Rong Ma, Haixia Cao, Changwen Jing, Zhuo Wang, Dan Chen, Junying Zhang, Yuan Zhang, Jifeng Feng, Jianzhong Wu
Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
Dong Xie, Ting-Ting Wang, Shu-Jung Huang, Jia-Jun Deng, Yi-Jiu Ren, Yang Yang, Jun-Qi Wu, Lei Zhang, Ke Fei, Xi-Wen Sun, Yun-Lang She, Chang Chen
A meta-analysis on immune checkpoint inhibitor efficacy for advanced non-small cell lung cancer between East Asians versus non-East Asians
Siyu Peng, Ariel Fangting Ying, Bee Choo Tai, Ross Andrew Soo
LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1
Ying Wu, Li Li, Qun Wang, Li Zhang, Can He, Xihua Wang, Hongbing Liu
The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer
Chao Zhao, Tao Jiang, Jiayu Li, Yan Wang, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Xuefei Li, Caicun Zhou
Radiological manifestations, histological features and surgical outcomes of pulmonary meningothelial proliferation: a case series and rethinking
Dong Lin, Yangli Yu, Hao Wang, Yong Fang, Jun Yin, Yaxing Shen, Lijie Tan
Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program
Luca Cantini, Robert A. Belderbos, Cornedine J. Gooijer, Daphne W. Dumoulin, Robin Cornelissen, Sara Baart, Jacobus A. Burgers, Paul Baas, Joachim G. J. V. Aerts
Recent trends in use of adjuvant chemotherapy in elderly stage II– III non-small cell lung cancer
Takefumi Komiya, Emily Powell, Achuta Kumar Guddati
Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis
Bin Zhang, Lianmin Zhang, Dongsheng Yue, Chenguang Li, Hua Zhang, Junyi Ye, Liuwei Gao, Xiaoliang Zhao, Chen Chen, Yansong Huo, Chong Pang, Yue Li, Yulong Chen, Shannon Chuai, Zhenfa Zhang, Giuseppe Giaccone, Changli Wang
Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
Trisari Anggondowati, Apar Kishor Ganti, K. M. Monirul Islam
3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma
Guixue Liu, Zhihan Xu, Yingqian Ge, Beibei Jiang, Harry Groen, Rozemarijn Vliegenthart, Xueqian Xie
Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma
Hualin Chen, Meilian Liu, Zhiwei Dai, Shujun Li, Yiping Luo, Yongcun Wang, Wenmei Su, Weijing Cai, Donghong Yang, Jian Huang, Zhixiong Yang
Three-dimensional reconstruction/personalized three-dimensional printed model for thoracoscopic anatomical partial-lobectomy in stage I lung cancer: a retrospective study
Bin Qiu, Ying Ji, Huayu He, Jun Zhao, Qi Xue, Shugeng Gao
Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion
Yuan Yang, Li Ma, Xin Qiao, Xin Zhang, Shu-Feng Dong, Min-Ting Wu, Kan Zhai, Huan-Zhong Shi
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
Wenfeng Fang, Yihua Huang, Weiguang Gu, Jiadi Gan, Wenjing Wang, Shiyue Zhang, Kai Wang, Jianhua Zhan, Yunpeng Yang, Yan Huang, Hongyun Zhao, Li Zhang
Dose-response relationship of stereotactic body radiotherapy for ultracentral tumor and comparison of efficacy with central tumor: a meta-analysis
Chai Hong Rim, In-Soo Shin, Won Sup Yoon, Sunmin Park
Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study
Yue Yu, Peng Zhang, Renqi Yao, Junnan Wang, Pei Wang, Xiaofei Xue, Jian Xiao, Zhinong Wang
Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
Jiaqi Liang, Ming Li, Qihai Sui, Zhengyang Hu, Yunyi Bian, Yiwei Huang, Cheng Zhan, Wei Jiang, Qun Wang, Lijie Tan
18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer
Li Li, Wei Zhao, Xiaorong Sun, Ning Liu, Yue Zhou, Xiaohui Luan, Song Gao, Shuqiang Zhao, Jinming Yu, Shuanghu Yuan
Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer
Hao Chen, Nobuyuki Horita, Kentaro Ito, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko
PD-L1 as a prognostic biomarker in surgically resectable non- small cell lung cancer: a meta-analysis
Stephanie Tuminello, Daniel Sikavi, Rajwanth Veluswamy, Cesar Gamarra, Wil Lieberman-Cribbin, Raja Flores, Emanuela Taioli
High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer
Qianping Li, Weijie Ma, Shuai Chen, Eddie C. Tian, Sixi Wei, Reggie R. Fan, Tao Wang, Chihong Zhou, Tianhong Li
Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell- maintenance factors and inducing apoptosis via the Hedgehog signaling blockade
Ke-Jie Chang, Ji-Zhong Yin, Hai Huang, Bing Li, Meng-Hang Yang
Predicting the invasiveness of lung adenocarcinomas appearing as ground-glass nodule on CT scan using multi-task learning and deep radiomics
Xiang Wang, Qingchu Li, Jiali Cai, Wei Wang, Peng Xu, Yiqian Zhang, Qu Fang, Chicheng Fu, Li Fan, Yi Xiao, Shiyuan Liu
Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients
Qihai Sui, Jiaqi Liang, Zhengyang Hu, Zhencong Chen, Guoshu Bi, Yiwei Huang, Ming Li, Cheng Zhan, Zongwu Lin, Qun Wang
Looking through the eyes of the multidisciplinary team: the design and clinical evaluation of a decision support system for lung cancer care
Jon R. Pluyter, Igor Jacobs, Sander Langereis, David Cobben, Sharon Williams, Jeannine Curfs, Ben van den Borne
Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer
Dirk Rades, Trang Nguyen, Stefan Janssen, Steven E. Schild
Radiomic features of primary tumor by lung cancer stage: analysis in BRAF mutated non-small cell lung cancer
Atul Padole, Ramandeep Singh, Eric W. Zhang, Dexter P. Mendoza, Ibiayi Dagogo-Jack, Mannudeep K. Kalra, Subba R. Digumarthy
Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusion
Meng Qiao, Chao Zhao, Qian Liu, Yan Wang, Jingyun Shi, Terry L. Ng, Fei Zhou, Xuefei Li, Tao Jiang, Shuo Yang, Guanghui Gao, Anwen Xiong, Jiayu Li, Wei Li, Fengying Wu, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou, Jun Zhang
Analysis of the clinical effect of osimertinib on 90 cases with advanced lung adenocarcinoma
Zhiqiang Gao, Weimin Wang, Aiqin Gu, Jianhong Lu, Aimi Huang, Liwen Xiong, Baohui Han, Liyan Jiang, Chunlei Shi
Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
Xiaojiang Sun, Yefei Li, Yaoyao Zhu, Qian Li, Xiaoshuai Yuan, Qingren Lin, Denghu Weng, Qinghua Xu, Hui Liu, Yaping Xu
CD39: the potential target in small cell lung cancer
Shanhao Chen, Shengyu Wu, Liping Zhang, Wei Zhang, Yu Liu, Bin Chen, Sha Zhao, Wei Li, Chenglong Sun, Lei Wang, Keyi Jia, Hao Wang, Peixin Chen, Chunyan Wu, Junjie Zhu, Yayi He, Caicun Zhou
Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution’s experience
Guangjin Chai, Yutian Yin, Xiaoying Zhou, Qilong Hu, Bo Lv, Zhaohui Li, Mei Shi, Lina Zhao
A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer
Shidai Jin, Chengzhi Zhou, Xue Hou, Zaiwen Fan, Jun Zhao, Xinghao Ai, Yuxing Chu, Rongrong Chen, Renhua Guo, Likun Chen
COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study
Ya-Jie Zhang, Wen-Jie Yang, Dong Liu, Yu-Qin Cao, Yu-Yan Zheng, Yi-Chao Han, Run-Sen Jin, Yu Han, Xiao-Yang Wang, A-Shan Pan, Jian-Yi Dai, Qing-Feng Sun, Feng-Quan Zhao, Qing-Yuan Yang, Jia-Hao Zhang, Sheng-Jun Liu, Qian Da, Wei Guo, Cheng-Qiang Li, Wen-Tian Zhang, Han Wu, Xing-Shi Chen, An-Qi Ji, Jie Xiang, Kai Chen, Xi-Jia Feng, Xian-Fei Zhang, Qi-Qi Cao, Le Qin, Jian Li, Min Zhou, Yong Lu, Chao-Fu Wang, Fu-Hua Yan, He-Cheng Li, Jie-Ming Qu

Brief Report

Rates of positive lung cancer screening examinations in academic versus community practice
Louise M. Henderson, Leon Bacchus, Thad Benefield, Roger Huamani Velasquez, M. Patricia Rivera
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab
Giuseppe Luigi Banna, Diego Signorelli, Giulio Metro, Domenico Galetta, Alessandro De Toma, Ornella Cantale, Marco Banini, Alex Friedlaender, Pamela Pizzutillo, Marina Chiara Garassino, Alfredo Addeo

Case Report

Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report
Sook Jung Yun, In-Jae Oh, Cheol Kyu Park, Young-Chul Kim, Hyeon Bin Kim, Hee-Kyung Kim, A. Ram Hong, In-Young Kim, Sung-Ja Ahn, Kook-Joo Na, Yoo-Duk Choi

Letter to the Editor

Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
Jiajun Deng, Yunlang She, Minglei Yang, Lei Zhang, Dong Xie, Chang Chen

Editorial on Lung Cancer Multidisciplinary Care1

Multidisciplinary team care in lung cancer
Emily Stone

Disclosure:

1. The series “Lung Cancer Multidisciplinary Care” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Emily Stone served as the unpaid Guest Editor of the series.

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future
Bryan A. Chan, Brett G.M. Hughes
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Global trends of lung cancer mortality and smoking prevalence
Farhad Islami, Lindsey A. Torre, Ahmedin Jemal
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review
Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao
Tackling ALK in non-small cell lung cancer: the role of novel inhibitors
Francesco Facchinetti, Marcello Tiseo, Massimo Di Maio, Paolo Graziano, Emilio Bria, Giulio Rossi, Silvia Novello
Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?
Silvia Calabuig-Fariñas, Eloísa Jantus-Lewintre, Alejandro Herreros-Pomares, Carlos Camps

Review Article on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care

Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
Jeryl Villadolid, Asim Amin

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis
Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song
BRAF mutations in non-small cell lung cancer
Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper
The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer
Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper
Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice
Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song
Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song
Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer
Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen
The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants
Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden
The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices
Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement
Hyojin Kim, Jin-Haeng Chung
Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review
Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao
Clinical trials for lung cancer in China
Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu
Recurrence after surgery in patients with NSCLC
Hidetaka Uramoto, Fumihiro Tanaka
Prognostic markers in lung cancer: is it ready for prime time?
Chang-Qi Zhu, Ming-Sound Tsao
Potential biomarkers for lung cancer screening
Gabriella Sozzi, Mattia Boeri
Particle therapy in non-small cell lung cancer
Zhongxing Liao, Charles B. Simone II
Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions
Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai
Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer
Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors
Suchit H. Patel, Andreas Rimner, Roger B. Cohen
Intraoperative near-infrared imaging of mesothelioma
Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal
BAP1, a tumor suppressor gene driving malignant mesothelioma
Mitchell Cheung, Joseph R. Testa
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation
Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Jordan Dozier, Hua Zheng, Prasad S. Adusumilli
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
Linda O’Flaherty, Harriet Wikman, Klaus Pantel
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Sumitra Mohan, Francesca Chemi, Ged Brady
Biophysical technologies for understanding circulating tumor cell biology and metastasis
Derrick W. Su, Jorge Nieva
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno
Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer
Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis
Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

Editorials

Dulanermin in cancer therapy: Still much to do
Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data
Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner
Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung
Pedro Mendez, Jose Luis Ramirez
Role of HGF/MET axis in resistance of lung cancer to contemporary management
Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr
Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review
Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack
Lorenza Landi, Federico Cappuzzo

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hyo Sup Shim
Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Original Article


Review Article